Vai al contenuto

JAMS

  • Home
  • JAMS Editions
    • JAMS 2018
    • JAMS 2019
    • JAMS 2021
    • JAMS 2022
    • JAMS 2023
    • JAMS 2024
    • JAMS 2025
  • JAMS Auditions
  • Contatti
  • Regolamento
  • Home
  • JAMS Editions
    • JAMS 2018
    • JAMS 2019
    • JAMS 2021
    • JAMS 2022
    • JAMS 2023
    • JAMS 2024
    • JAMS 2025
  • JAMS Auditions
  • Contatti
  • Regolamento

Anno: 2024

Considering DMT discontinuation in older patients with Multiple Sclerosis: who, when and how?

Unveiling the Spectrum of Cognitive Decline in MS: Beyond the Binary

Role of RNA binding protein HuR in the pathogenesis and rate of progression of Multiple Sclerosis

Leptomeningeal inflammation and synaptic pathology in Multiple Sclerosis cortex

Is NEDA3 enough in multiple sclerosis? A longitudinal study inlcuding plasma neurofilament light chain in NEDA3 definition

Enhancing MS diagnosis: leveraging deep learning to classify lesions using standard MRI sequences

Sleep Disorders in Multiple Sclerosis: Implication for Motor and Cognitive Decline

Interrogation of Multiple Sclerosis Prodromes using digital health data: a retrospective-prospective observational study

HLAs: an “old new” way to understand and individualize treatment response

Characterization of grey matter damage with Soma and Neurite Density Imaging metrics in multiple sclerosis and its correlation with disability

← meno recenti

JAMS

Junior Academy Multiple Sclerosis

info@neurojams.it

Legal hub

Privacy Policy

Cookie Policy

© All rights reserved – JAMS – Designed by Sfeezio